Jacobs Levy Equity Management
VXRT

Jacobs Levy Equity Management’s Vaxart VXRT Stock Holding History

Jacobs Levy Equity Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,254
Closed -$52K – 1024
2017
Q1 		$52K Sell
7,254
-873
-11% -$8.93K ﹤0.01% 894
2016
Q4 		$110K Hold
8,127
– – ﹤0.01% 898
2016
Q3 		$172K Sell
8,127
-850
-9% -$13.4K ﹤0.01% 926
2016
Q2 		$138K Sell
8,977
-805
-8% -$13.4K ﹤0.01% 1061
2016
Q1 		$161K Sell
9,782
-3,607
-27% -$64.3K ﹤0.01% 1000
2015
Q4 		$286K Sell
13,389
-537
-4% -$11.8K 0.01% 659
2015
Q3 		$303K Buy
13,926
+874
+7% +$21.2K 0.01% 652
2015
Q2 		$297K Sell
13,052
-491
-4% -$12.1K 0.01% 663
2015
Q1 		$343K Buy
+13,543
New +$373K 0.01% 628

Other funds holding VXRT

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TL
TowerView LLC New York $155M AUM 30.14% 1-Year Est. Return

Jacobs Levy Equity Management's VXRT Position: Q2 2017 in Review

Jacobs Levy Equity Management sold out of Vaxart (VXRT) in Q2 2017, closing a stake of 7,254 shares — an estimated $52K sold.

Jacobs Levy Equity Management first reported a position in VXRT in Q1 2015 and held it in 9 quarters. The position peaked at $343K in Q1 2015. 32 funds tracked by Wall St. Rank hold VXRT as of Q2 2017.

  • Jacobs Levy Equity Management reported no remaining Vaxart position as of Q2 2017 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 7,254 Vaxart shares in Q2 2017, an estimated $52K.
  • Jacobs Levy Equity Management first reported a position in Vaxart in Q1 2015 and held it in 9 quarters.
  • Jacobs Levy Equity Management's Vaxart position peaked at $343K in Q1 2015.
  • 32 funds tracked by Wall St. Rank held Vaxart as of Q2 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.